首页> 外文期刊>老年心脏病学杂志(英文版) >Embolic protection device, the next advancement in TAVR?
【24h】

Embolic protection device, the next advancement in TAVR?

机译:栓塞保护装置,TAVR的下一个进步?

获取原文
获取原文并翻译 | 示例
       

摘要

The approval of commercial application transcatheter aortic valve replacement(TAVR)by the FDA in 2011 has revolutionized the management of high-risk surgical patients with severe aortic stenosis(AS).With TAVR being expanded to intermediate surgical risk patients in 2016,the number of patients undergoing TAVR has been increasing rapidly.In fact,since the very first human TAVR procedure in 2002,more than 300,000 TAVRs have been performed worldwide.[1,2]The technological advancements in the TAVR since its early days of clinical adaptation has made this procedure a routine practice in many institutions worldwide.However,one of the most feared complications,ischemic stroke,remains a major concern for clinicians and patients despite all the advancements in the procedure.

著录项

  • 来源
    《老年心脏病学杂志(英文版)》 |2020年第3期|160-163|共4页
  • 作者单位

    Department of Anesthesiology and Pain Medicine University of California Davis Health Sacramento CA USA;

  • 收录信息 中国科学引文数据库(CSCD);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-19 04:41:55
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号